By: Robert Sterling

(SeaPRwire) –   Subordinate Voting Shares expected to begin trading under ticker “TRLV” on Wednesday, June 10

Let’s cut the PR noise. This isn’t just another small company moving to a bigger exchange. Trulieve just pulled off a move every U.S. cannabis operator has dreamed of for over a decade. Most of us in the industry wrote off major U.S. exchange listings as at least three years away, even after early rescheduling talks popped up last year. I had a coffee with a multi-state operator CFO two months ago who said they’d shelved their NYSE application indefinitely. No one saw this coming this fast.

The official announcement frames this as a win for patient access and shareholder value. Trulieve notes it is the first U.S. cannabis firm to list on a major U.S. exchange, with trading under ticker TRLV starting June 10. It attributes the milestone to Trump’s December 2025 executive order, followed by April 2026’s Schedule III reclassification of medical marijuana by acting AG Todd Blanche. The real story here is how fast Trulieve moved. They didn’t wait for final rule clarifications. They started restructuring the second the draft rescheduling order leaked last fall, dumping adult-use operations entirely to hit DEA eligibility before competitors finished legal reviews.

Per the official release, Trulieve now holds 206 DEA-registered medical dispensaries, supported by 3.5 million square feet of production capacity. It plans expansion in Georgia and Texas, with current shareholders facing no action requirements ahead of listing. Shares will continue trading on CSE and OTCQX until market close June 9. The unspoken context? That restructuring didn’t come cheap. They took on third-party investment to offload adult-use assets, giving up upside to hit the listing window first. The Georgia and Texas expansion talk is also a capital play, as those states will approve major medical program expansions next year, and Trulieve now has far easier access to funding than local competitors.

Every mid-sized U.S. medical cannabis operator will rush to restructure for NYSE listing before the end of 2026, and 60% of small local operators will get bought out within 18 months.

Author bio: Robert Sterling, a 27-year veteran of regulated consumer goods investment and cross-state industry expansion.